Company / Assets per Share
Oric Pharmaceuticals, Inc. Assets per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$4.66
FY2025
5-year range
$3.93 / $7.87
FY2021-FY2025
Trend
+18.5%
vs FY2024
Sector context
#151 of 210
Health Care
What the data says
At $4.66, Oric Pharmaceuticals, Inc.'s assets per share ranks #151 of 210 in the Health Care sector. Assets per Share returned to growth in FY2025 after 5 years of decline, reaching $4.66.
Based on SEC 10-K filings.
4.66 in FY2025 with a 5-year CAGR of -19.3%.
Declined from $4.90 to $4.66 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -9.3%
- 5-Year CAGR
- -19.3%
- 10-Year CAGR
- -
Sector benchmark
#151 of 210 in Health CareTop 72% of 210This company $4.66 Sector average $353.15
▼
-98.7% below sector average
Key checks
Key Insights
- In FY2025, assets per share increased 18.5% year-over-year.
- Ranks #151 out of 210 companies in the Health Care sector.
- Peak assets per share was recorded in FY2019.
- Lowest assets per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 5.96 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.66 | +18.5% |
| FY2024 | $3.93 | -19.7% |
| FY2023 | $4.90 | -21.4% |
| FY2022 | $6.23 | -20.8% |
| FY2021 | $7.87 | -42.3% |
| FY2020 | $13.63 | -72.5% |
| FY2019 | $49.54 | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026